Advertisement
Journal Home
Search for

Volume 45, Issue 12, Pages e227-e231 (December 2009)


View previous. 5 of 25 View next.

The assessment of diffused light illumination and acetic acid rinse (Microlux/DL™) in the visualisation of oral mucosal lesions

Lidija McIntosha, Michael J. McCulloughb, Camile S. FarahaCorresponding Author Informationemail address

Received 3 July 2009; received in revised form 3 August 2009; accepted 3 August 2009. published online 05 October 2009.

Summary 

Oral examination alone cannot always distinguish benign from premalignant and malignant lesions, thereby resulting in delayed patient referral and poorer prognosis. Thus, any non-invasive technology which highlights oral premalignant and malignant lesions in a highly sensitive and specific manner will undoubtedly aid clinicians in early diagnosis and treatment of these conditions. The aim of this study was to assess the efficacy of acetic acid mouthwash and diffused light illumination (Microlux/DL™) as a diagnostic aid in the visualisation of oral mucosal lesions and its ability to highlight malignant and potentially malignant lesions. Fifty patients referred for assessment of an oral white lesion were initially examined under routine incandescent operatory light. The location, size, ease of visibility, border distinctness and presence of satellite lesions were recorded. Clinical examination was repeated using the Microlux/DL diffused light illumination kit. An incisional biopsy was performed to provide a definitive histopathological diagnosis. Microlux/DL examination enhanced the visibility of 34 lesions, however, it did not help uncover any clinically undetected lesions, change the provisional diagnosis, or alter the biopsy site. Microlux/DL showed a sensitivity of 77.8% and a specificity of 70.7%, with a positive predictive value of 36.8%. Although Microlux/DL appears useful at enhancing lesion visibility, it is a poor discriminator for inflammatory, traumatic and malignant lesions.

a School of Dentistry and UQ Centre for Clinical Research, The University of Queensland, Australia

b Melbourne Dental School, The University of Melbourne, Australia

Corresponding Author InformationCorresponding author. Address: Level 5, UQ Centre for Clinical Research, Royal Brisbane & Women’s Hospital, University of Queensland, Herston, QLD 4029, Australia. Tel.: +61 7 3346 6030; fax: +61 7 3346 6098.

PII: S1368-8375(09)00878-1

doi:10.1016/j.oraloncology.2009.08.001


View previous. 5 of 25 View next.

Advertisement